当前位置:药药网 / 数据中心 / 儿科研究特征电子表格
Aklief
儿科标签批准日期
2019/10/4 0:00:00
标签更改摘要
- Safety and effectiveness for the topical treatment of acne vulgaris have been established in pediatric patients age 9 years to 17 years based on evidence from well-controlled clinical trials, a long-term safety trial, and a pharmacokinetic trial. A total of 897 pediatric subjects aged 9 to 17 years received Aklief Cream in the clinical trials
- Safety and effectiveness have not been established in pediatric subjects under the age of 9 years.
- Information on PK parameters and clinical trials.